Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • World View
  • Published:

Drug development needs a new brand of science

Nature volume 468, page 869 (2010)Cite this article

Subjects

We need to break with the past to develop new medicines, says Garret FitzGerald. An interdisciplinary NIH centre points the way.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Garret FitzGerald is director of the Institute of Translational Medicine and Therapeutics at the University of Pennsylvania in Philadelphia. garret@exchange.upenn.edu ,

    Garret FitzGerald

Authors
  1. Garret FitzGerald
    View author publications

    Search author on:PubMed Google Scholar

Additional information

See News p.877

Rights and permissions

Reprints and permissions

About this article

Cite this article

FitzGerald, G. Drug development needs a new brand of science. Nature 468, 869 (2010). https://doi.org/10.1038/468869a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/468869a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing